{"id":"https://openalex.org/W4394598513","doi":"https://doi.org/10.1212/wnl.0000000000206723","title":"A Retrospective Cohort Study of Recent Large Multiple Commercial Payer Databases to Elucidate Migraine-specific Costs of Care by specific Treatment Groups (P1-12.006)","display_name":"A Retrospective Cohort Study of Recent Large Multiple Commercial Payer Databases to Elucidate Migraine-specific Costs of Care by specific Treatment Groups (P1-12.006)","publication_year":2024,"publication_date":"2024-04-09","ids":{"openalex":"https://openalex.org/W4394598513","doi":"https://doi.org/10.1212/wnl.0000000000206723"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.0000000000206723","doi":"https://doi.org/10.1212/wnl.0000000000206723","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000206723","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022099384","display_name":"Olya Besedina","orcid":"https://orcid.org/0009-0001-3429-3740","observed_orcids":["https://orcid.org/0009-0001-3429-3740"]},"institutions":[{"id":"https://openalex.org/I4405268034","display_name":"Click Therapeutics, Inc. (United States)","ror":"https://ror.org/05frdy048","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268034"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Olya Besedina","raw_affiliation_strings":["Click Therapeutics Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Click Therapeutics Inc","institution_ids":["https://openalex.org/I4405268034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040497269","display_name":"Mariya Petrova","orcid":"https://orcid.org/0000-0002-6343-2359","observed_orcids":["https://orcid.org/0000-0002-6343-2359"]},"institutions":[{"id":"https://openalex.org/I4405268034","display_name":"Click Therapeutics, Inc. (United States)","ror":"https://ror.org/05frdy048","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268034"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mariya Petrova","raw_affiliation_strings":["Click Therapeutics Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Click Therapeutics Inc","institution_ids":["https://openalex.org/I4405268034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018764701","display_name":"Brendan D. Hare","orcid":"https://orcid.org/0000-0002-6502-3188","observed_orcids":["https://orcid.org/0000-0002-6502-3188"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Brendan Hare","raw_affiliation_strings":["Boehringer-Ingelheim Pharmaceuticals"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer-Ingelheim Pharmaceuticals","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087148691","display_name":"Alankar Gupta","orcid":"https://orcid.org/0000-0002-2672-6403","observed_orcids":["https://orcid.org/0000-0002-2672-6403"]},"institutions":[{"id":"https://openalex.org/I4405268034","display_name":"Click Therapeutics, Inc. (United States)","ror":"https://ror.org/05frdy048","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268034"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alankar Gupta","raw_affiliation_strings":["Click Therapeutics Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Click Therapeutics Inc","institution_ids":["https://openalex.org/I4405268034"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079941092","display_name":"Shaheen Emmanuel Lakhan","orcid":"https://orcid.org/0000-0002-2994-3630","observed_orcids":["https://orcid.org/0000-0002-2994-3630"]},"institutions":[{"id":"https://openalex.org/I4405268034","display_name":"Click Therapeutics, Inc. (United States)","ror":"https://ror.org/05frdy048","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268034"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shaheen Lakhan","raw_affiliation_strings":["Click Therapeutics Inc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Click Therapeutics Inc","institution_ids":["https://openalex.org/I4405268034"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"102","issue":"7_supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10420","display_name":"Intracranial Aneurysms: Treatment and Complications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/migraine","display_name":"migraine","score":0.9800000190734863},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.7559999823570251},{"id":"https://openalex.org/keywords/chronic-migraine","display_name":"chronic migraine","score":0.7979999780654907},{"id":"https://openalex.org/keywords/pharmacy-costs","display_name":"pharmacy costs","score":0.8029999732971191},{"id":"https://openalex.org/keywords/migraine-prevention","display_name":"migraine prophylaxis","score":0.6100000143051147},{"id":"https://openalex.org/keywords/acute-migraine-treatment","display_name":"acute migraine treatment","score":0.6610000133514404},{"id":"https://openalex.org/keywords/treatment-groups","display_name":"treatment groups","score":0.41200000047683716},{"id":"https://openalex.org/keywords/cost-comparison","display_name":"cost comparison","score":0.36500000953674316}],"concepts":[{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.8247932195663452},{"id":"https://openalex.org/C2778541695","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Migraine","level":2,"score":0.8230174779891968},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7144599556922913},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.6640611290931702},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.5314010381698608},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.5196275115013123},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.3383132219314575},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.32496950030326843},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21531593799591064}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.0000000000206723","doi":"https://doi.org/10.1212/wnl.0000000000206723","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000206723","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4394600494","https://openalex.org/W4316927696","https://openalex.org/W4394598272","https://openalex.org/W6902236898","https://openalex.org/W4293373674","https://openalex.org/W4283515325","https://openalex.org/W4288032865","https://openalex.org/W4389000077","https://openalex.org/W4389859473","https://openalex.org/W6958501417"],"abstract_inverted_index":{"Objective:":[0],"This":[1,56,218,257],"Retrospective":[2],"observational":[3],"cohort":[4],"analysis":[5,219],"of":[6,23,34,220,232,263,285,306,320,334,353,375,403,412,415],"migraine":[7],"patients":[8],"in":[9,212,251,350,372,400,425],"the":[10,15,21,35,113,119,130,142,148,154,171,198,213,229,259,351,373,401,413],"US":[11,65],"aimed":[12],"to":[13,170,197,293],"evaluate":[14],"current":[16,59],"medication":[17,60,222],"costs":[18,70,223,244,269],"associated":[19],"with":[20],"treatment":[22,28,72,127,139,173,200,226],"Migraine,":[24,31],"stratified":[25],"by":[26,71],"distinct":[27],"groups.":[29,73,140,272],"Background:":[30],"affecting":[32],"14%":[33],"population,":[36],"is":[37,165,192,210],"a":[38,358,380],"significant":[39],"healthcare":[40,268],"burden.":[41],"While":[42],"generic":[43],"treatments":[44,265],"are":[45],"affordable,":[46],"newer":[47],"anti-CGRP":[48,155,186,233,236,264],"(calcitonin":[49],"gene-related":[50],"peptide)":[51],"medications":[52],"may":[53],"raise":[54],"costs.":[55],"study":[57],"examines":[58],"expenses":[61,250],"within":[62,145,224,270],"our":[63],"large":[64],"Migraine":[66,75,83,147,215,225,255],"patient":[67,161],"group,":[68],"stratifying":[69],"Design/Methods:":[74],"cases":[76],"were":[77,89],"categorized":[78],"as":[79,282,303,317,331,357,407],"Chronic":[80,146,252],"or":[81,99,102,383,410],"Other":[82,214,254],"using":[84],"ICD-10":[85],"codes.":[86],"Treatment":[87],"groups":[88,227],"determined":[90],"hierarchically":[91],"based":[92],"on":[93,266,379],"baseline":[94],"treatments:":[95],"anti-CGRP,":[96],"non-specific":[97],"preventive":[98],"acute":[100],"treatment,":[101],"no":[103],"treatment.":[104],"Data":[105,384],"from":[106],"Health":[107],"Verity,":[108],"comprising":[109],"187,780":[110],"cases,":[111],"covered":[112],"12-month":[114],"periods":[115],"before":[116],"and":[117,134,164,191,248,253],"after":[118],"index":[120],"date":[121],"(8/1/2018":[122],"\u2013":[123],"7/31/2021).":[124],"Results:":[125],"Anti-CGRP":[126],"group":[128,156,174,187,201,237],"had":[129],"highest":[131],"total":[132,150],"pharmacy":[133,151],"medical":[135],"cost":[136,152],"among":[137],"all":[138],"During":[141],"follow-up":[143],"period,":[144],"Migraine-Specific":[149],"for":[153,185,245,280,301,315,329,355,360,377,388,405,417],"was":[157,188],"$5,555":[158],"PPPY":[159,190],"(per":[160],"per":[162],"year)":[163],"6.5":[166],"times":[167,194],"higher":[168,195,241],"compared":[169,196],"next":[172,199],"-":[175,178,202,205],"Preventative":[176,203],"Non-Specific":[177,204],"$857":[179],"PPPY.":[180],"All-Cause":[181],"Total":[182,242],"Pharmacy":[183,243],"Cost":[184],"$9,331":[189],"2.4":[193],"$3,882.":[206],"The":[207,235,339],"same":[208],"trend":[209],"observed":[211],"group.":[216],"Conclusions:":[217],"recent":[221],"reveals":[228],"dominant":[230],"impact":[231],"medications.":[234],"consistently":[238],"exhibits":[239],"markedly":[240],"both":[246],"all-cause":[247],"migraine-specific":[249],"categories.":[256],"underscores":[258],"profound":[260],"financial":[261],"influence":[262],"overall":[267],"these":[271],"Disclosure:":[273],"Miss":[274],"Besedina":[275],"has":[276,291,297,311,325,346,368,396,423],"received":[277,298,312,326,347,369,397],"personal":[278,299,313,327,348,370,398],"compensation":[279,300,314,328,349,371,399],"serving":[281,302,316,330,356,378,406],"an":[283,304,318,332,408],"employee":[284,305,319,333],"Click":[286,307,321,342,418,428],"Therapeutics":[287],"Inc.":[288],"Dr.":[289,309,323,344,366,394,421],"Petrova":[290],"nothing":[292],"disclose.":[294],"Mr.":[295],"Hare":[296],"Therapeutics.":[308,322,343],"Gupta":[310],"Lakhan":[324,345,367,395,422],"Zogenix,":[335,426],"Fern":[336,390],"Health,":[337,391],"Thriveworks,":[338],"Learning":[340],"Corp,":[341],"range":[352,374,402],"$1,000,000+":[354],"Consultant":[359],"Shaheen":[361],"Lakhan,":[362],"MD,":[363],"PhD,":[364],"LLC.":[365],"$100,000-$499,999":[376],"Scientific":[381],"Advisory":[382],"Safety":[385],"Monitoring":[386],"board":[387],"Neurocrine,":[389],"Lin":[392],"Health.":[393],"$500,000-$999,999":[404],"officer":[409],"member":[411],"Board":[414],"Directors":[416],"Therapeutics,":[419,429],"SpineThera.":[420,430],"stock":[424],"NeuroSport,":[427]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2024-04-10T00:00:00"}